Delisting risk
XORTX Therapeutics (XRTX)
Develops oral oxypurinol therapies for gout and kidney disease.
$2.42
At close+0.26 (+12.04%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
estimated · in 70 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Feb '26May '26May '26Aug '26Nov '26
Reported−$0.19−$0.19−$0.13−$0.45−$0.58−$0.58−$1.05Pending
Estimate−$0.27−$0.25−$0.17−$0.84————
Surprise+29.6%+24.0%+22.2%+46.1%————
RevenueReportedEstimate
May '25Aug '25Nov '25Feb '26May '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Aug 2026 | — | −$1.05 | — |
| May 2026 | — | −$0.58 | — |
| May 2026 | — | −$0.58 | — |
| Feb 2026 | −$0.84 | −$0.45 | +46.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| May 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Apr 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | — | — | — | — | — | — | — |
| Aug 17, 2026 | — | −$1.05 | — | — | — | — | −4.2% |
| May 19, 2026 | — | −$0.58 | — | — | — | — | +4.7% |
| May 15, 2026 | — | −$0.58 | — | — | — | — | +0.4% |
| Feb 26, 2026 | −$0.84 | −$0.45 | +46.1% | — | — | — | +1.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Aug 14, 2025 | |||||||
| May 19, 2025 | |||||||
| May 15, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 2, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 13, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Nov 29, 2021 | |||||||
| Aug 27, 2021 | |||||||
| May 31, 2021 | |||||||
| Nov 30, 2020 | |||||||
| Aug 31, 2020 | |||||||
| Jun 1, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| May 31, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 30, 2016 | |||||||
| Aug 31, 2016 | |||||||
| May 31, 2016 | |||||||
| Feb 29, 2016 | |||||||
| Nov 30, 2015 | |||||||
| Aug 31, 2015 | |||||||